loadpatents
Patent applications and USPTO patent grants for Yamazaki; Chihiro.The latest application filed is for "peptides having osteoblast growth-promoting activity and use thereof".
Patent | Date |
---|---|
Anti-PAD4 antibody Grant 11,447,569 - Sato , et al. September 20, 2 | 2022-09-20 |
Anticancer agents or antimetastatic agents using FSTL1 and combination drug thereof Grant 10,806,787 - Kudo , et al. October 20, 2 | 2020-10-20 |
Peptides Having Osteoblast Growth-promoting Activity And Use Thereof App 20200157165 - YAMAZAKI; Chihiro ;   et al. | 2020-05-21 |
Peptides having osteoblast growth-promoting activity and use thereof Grant 10,538,564 - Yamazaki , et al. Ja | 2020-01-21 |
Novel Anti-pad4 Antibody App 20180044434 - SATO; Mamoru ;   et al. | 2018-02-15 |
Anticancer Agents Or Antimetastatic Agents Using Fstl1 And Combination Drug Thereof App 20180021429 - KUDO; Chie ;   et al. | 2018-01-25 |
Peptides Having Osteoblast Growth-promoting Activity And Use Thereof App 20160362466 - YAMAZAKI; Chihiro ;   et al. | 2016-12-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.